Showing results (91-100 of 103) with videos related to
Sort By:
Pageof 11
Journal of Clinical Pathology|August 1, 1992
HER2 (c-erbB-2) oncoprotein expression in colorectal adenocarcinoma: an immunohistological study using three different antibodiesA H Arnaout, P M Dawson, S Soomro, et al.Cancer Gene Therapy|March 1, 1996
Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 proteinM P Harris, S Sutjipto, K N Wills, et al.Journal of Clinical Immunology|May 11, 1991
Monoclonal antibody therapy of human cancer: taking the HER2 protooncogene to the clinicH M Shepard, G D Lewis, J C Sarup, et al.The Journal of Biological Chemistry|August 5, 1991
p185HER2 signal transduction in breast cancer cellsG K Scott, J M Dodson, P A Montgomery, et al.Proceedings of the National Academy of Sciences of the United States of America|May 15, 1992
Humanization of an anti-p185HER2 antibody for human cancer therapyP Carter, L Presta, C M Gorman, et al.Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|June 1, 1995
Recombinant human retinoblastoma protein inhibits cancer cell growthL C Pagliaro, D Antelman, D E Johnson, et al.International Journal of Cancer|September 17, 1996
Adenovirus-mediated p53 gene transfer suppresses growth of human glioblastoma cells in vitro and in vivoH Köck, M P Harris, S C Anderson, et al.Leukemia & Lymphoma|June 27, 1998
Enhancement of adenovirus-mediated gene transfer to human bone marrow cellsT Watanabe, L Kelsey, A Ageitos, et al.Biochemical Pharmacology|February 13, 2001
Enzyme-catalyzed therapeutic agent (ECTA) design: activation of the antitumor ECTA compound NB1011 by thymidylate synthaseD B Lackey, M P Groziak, M Sergeeva, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|August 1, 2006
A recombinant human enzyme for enhanced interstitial transport of therapeuticsL H Bookbinder, A Hofer, M F Haller, et al.Pageof 11